UPDATE : Wednesday, December 11, 2019
상단여백
‘Novartis’ Kymriah takes one step closer to cancer cure’ by Lee Han-soo 2019-11-14 13:24
iCure to apply for testing incrementally modified cancer drugs in US by Lee Han-soo 2019-11-13 17:35
JW Pharmaceutical launches joint-stock company in Vietnam by Lee Han-soo 2019-11-13 16:52
‘Generic drugs must indicate ingredient names on label’ by Kim Yun-mi 2019-11-13 15:51
Daewoong releases trial results for autoimmune disease treatment in US by Lee Han-soo 2019-11-12 14:09
라인
Hanmi to get ￦11.6 billion in royalty if FDA approves Rolontis by Lee Han-soo 2019-11-11 18:02
Genexine’s new immunotherapy shows stability even in high dose by Jeong Sae-im 2019-11-11 13:36
Medpacto releases trial results at US conference by Lee Han-soo 2019-11-11 13:27
Yuhan, Cyclica to co-develop new drugs by Lee Han-soo 2019-11-07 18:01
Takeda’s labor turmoil goes to extremes amid rumored unit sell-off by Kim Yun-mi 2019-11-07 16:10
라인
‘One-third of heart attack survivors overlook risk of recurrence’ by Lee Han-soo 2019-11-06 16:34
AbbVie’s hepatitis C drug gets 8-week therapy regardless of cirrhosis by Kim Yun-mi 2019-11-06 16:00
Crystal Genomics, Daehwa win patent for patch-form arthritis drug by Lee Han-soo 2019-11-06 15:57
Dong-A ST's treatment of nail athlete's foot dominates local market by Lee Han-soo 2019-11-06 14:09
Regulator to consider re-classifying choline alfoscerate as functional food by Kim Yun-mi 2019-11-06 13:54
라인
Daewoong to sell Merck's cardiovascular disease treatment by Lee Han-soo 2019-11-05 15:05
Merck Korea hurries to close GM part despite union’s protest by Kim Yun-mi 2019-11-05 15:04
[Interview with global pharmas] 'Pfizer Korea combines Pfizer's outstanding innovation with Koreans’ talents' by Lee Han-soo 2019-11-05 12:46
Yuhan, Dong-A, HanAll see Q3 earnings jump on licensing-out deals by Jeong Sae-im 2019-11-04 15:52
Takeda Korea fires union leader to worsen labor-management dispute by Kim Yun-mi 2019-11-04 15:03
-12345678910-
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
여백
Most viewed
여백
Opinion
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Reporter's Notebook] Korean biopharmaceuticals have long way to go before reaching foreigners
[Column] Korea should do better in diabetes management
[Column] Korea should do better in diabetes management
[Column] Digital healthcare for efficient distribution of medical resources
[Column] Digital healthcare for efficient distribution of medical resources
여백
Back to Top